KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

QuidelOrtho (QDEL) Cash & Equivalents (2021 - 2025)

QuidelOrtho (QDEL) has disclosed Cash & Equivalents for 5 consecutive years, with $98.1 million as the latest value for Q3 2025.

  • Quarterly Cash & Equivalents fell 31.87% to $98.1 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $98.1 million through Sep 2025, down 31.87% year-over-year, with the annual reading at $98.3 million for FY2024, 17.74% down from the prior year.
  • Cash & Equivalents hit $98.1 million in Q3 2025 for QuidelOrtho, down from $151.7 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $1.3 billion in Q2 2022 to a low of $79.0 million in Q1 2024.
  • Historically, Cash & Equivalents has averaged $319.3 million across 5 years, with a median of $165.6 million in 2023.
  • Biggest five-year swings in Cash & Equivalents: crashed 77.74% in 2024 and later skyrocketed 60.89% in 2025.
  • Year by year, Cash & Equivalents stood at $578.4 million in 2021, then crashed by 63.14% to $213.2 million in 2022, then tumbled by 43.95% to $119.5 million in 2023, then decreased by 17.74% to $98.3 million in 2024, then decreased by 0.2% to $98.1 million in 2025.
  • Business Quant data shows Cash & Equivalents for QDEL at $98.1 million in Q3 2025, $151.7 million in Q2 2025, and $127.1 million in Q1 2025.